Name: UMIN ID:
Unique ID issued by UMIN | UMIN000017895 |
---|---|
Receipt number | R000020733 |
Scientific Title | Investigation on Efficacy and Safety of Apixaban in Japanese Elderly Patients: Investigator-Initiated Multicenter Prospective Cohort Study |
Date of disclosure of the study information | 2015/06/13 |
Last modified on | 2020/06/17 09:05:23 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/06/13 10:38:46 | ||
2 | Update | 2015/06/17 19:40:49 | Public title |
|
3 | Update | 2015/12/14 09:17:48 | Recruitment status Last follow-up date Other related information Other related information |
|
4 | Update | 2016/06/13 20:45:58 | Name of primary person or sponsor Organization |
|
5 | Update | 2016/06/13 20:47:09 | Other related information Other related information |
|
6 | Update | 2016/06/30 12:05:48 | Last follow-up date |
|
7 | Update | 2016/12/14 17:02:17 | Recruitment status Other related information Other related information |
|
8 | Update | 2017/12/15 10:20:33 | Other related information Other related information |
|
9 | Update | 2018/06/15 13:05:38 | Date of closure to data entry Date trial data considered complete |
|
10 | Update | 2020/06/17 08:46:04 | 1st name of lead principal investigator Middle name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Middle name of lead principal investigator Last name of lead principal investigator Zip code Address Address Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
11 | Update | 2020/06/17 08:59:32 | Recruitment status Date of IRB Other related information Other related information |
|
12 | Update | 2020/06/17 09:05:23 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |